Endotronix inks $45 mln Series D

Lisle, Illinois-based Endotronix Inc, a digital health focused on advancing the treatment of heart failure, has raised $45 million in Series D funding. LSP led the round with participation from other investors that included Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors and Wanxiang Healthcare Investments.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!